Factors Associated with Acute and Chronic Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based GVHD Prophylaxis | Synapse
March 3, 2026
Factors Associated with Acute and Chronic Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based GVHD Prophylaxis
Key Points
Graft-versus-host disease occurs in both acute and chronic forms, impacting recovery after transplantation.
Key participant characteristics, including donor type and immunosuppression protocol, affect GVHD incidence.
Analysis focuses on data following unrelated donor hematopoietic cell transplantation to identify risk factors for GVHD.
Findings highlight the need for tailored prophylaxis strategies to improve patient outcomes post-transplant.